Aerie Pharmaceuticals Stock Price To Sales
| AERIDelisted Stock | USD 15.25 0.01 0.07% |
Aerie Pharmaceuticals fundamentals help investors to digest information that contributes to Aerie Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aerie Stock. The fundamental analysis module provides a way to measure Aerie Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aerie Pharmaceuticals stock.
Aerie |
Aerie Pharmaceuticals Company Price To Sales Analysis
Aerie Pharmaceuticals' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Aerie Pharmaceuticals Price To Sales | 3.52 X |
Most of Aerie Pharmaceuticals' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aerie Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Aerie Pharmaceuticals has a Price To Sales of 3.5225 times. This is 83.54% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 69.15% higher than that of the company.
Aerie Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aerie Pharmaceuticals' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aerie Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aerie Pharmaceuticals by comparing valuation metrics of similar companies.Aerie Pharmaceuticals is currently under evaluation in price to sales category among related companies.
Aerie Fundamentals
| Return On Equity | -22.55 | |||
| Return On Asset | -0.0459 | |||
| Profit Margin | (0.17) % | |||
| Operating Margin | (0.12) % | |||
| Current Valuation | 918.14 M | |||
| Shares Outstanding | 49.42 M | |||
| Shares Owned By Insiders | 1.79 % | |||
| Shares Owned By Institutions | 98.21 % | |||
| Number Of Shares Shorted | 1.52 M | |||
| Price To Earning | (19.00) X | |||
| Price To Book | 34.26 X | |||
| Price To Sales | 3.52 X | |||
| Revenue | 194.13 M | |||
| Gross Profit | 167.29 M | |||
| EBITDA | (7.81 M) | |||
| Net Income | (74.81 M) | |||
| Cash And Equivalents | 184.37 M | |||
| Cash Per Share | 3.73 X | |||
| Total Debt | 234.53 M | |||
| Debt To Equity | 9.41 % | |||
| Current Ratio | 2.60 X | |||
| Book Value Per Share | 0.51 X | |||
| Cash Flow From Operations | (99.15 M) | |||
| Short Ratio | 1.91 X | |||
| Earnings Per Share | (1.47) X | |||
| Target Price | 15.35 | |||
| Number Of Employees | 376 | |||
| Beta | -0.062 | |||
| Market Capitalization | 753.62 M | |||
| Total Asset | 431.39 M | |||
| Retained Earnings | (919.58 M) | |||
| Working Capital | 121.31 M | |||
| Current Asset | 138.43 M | |||
| Current Liabilities | 17.12 M | |||
| Z Score | -4.8 | |||
| Net Asset | 431.39 M |
About Aerie Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aerie Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aerie Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aerie Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aerie Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aerie Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerie Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Aerie Stock
| 0.49 | T | ATT Inc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Aerie Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aerie Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aerie Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aerie Pharmaceuticals to buy it.
The correlation of Aerie Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aerie Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aerie Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aerie Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Aerie Stock
If you are still planning to invest in Aerie Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aerie Pharmaceuticals' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |